Full Text

Turn on search term navigation

© 2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Potassium octatitanate fibers (K2O·8TiO2, POT fibers) are widely used as an alternative to asbestos. We investigated the pulmonary and pleural toxicity of POT fibers with reference to 2 non-fibrous titanium dioxide nanoparticles (nTiO2), photoreactive anatase (a-nTiO2) and inert rutile (r-nTiO2). Ten-week-old male F344 rats were given 0.5 mL of 250 μg/mL suspensions of POT fibers, a-nTiO2, or r-nTiO2, 8 times (1 mg/rat) over a 15-day period by trans-tracheal intrapulmonary spraying (TIPS). Rats were killed at 6 hours and at 4 weeks after the last TIPS dose. Alveolar macrophages were significantly increased in all treatment groups at 6 hours and at 4 weeks. At week 4, a-nTiO2 and r-nTiO2 were largely cleared from the lung whereas a major fraction of POT fibers were not cleared. In the bronchoalveolar lavage, alkaline phosphatase activity was elevated in all treatment groups, and lactate dehydrogenase (LDH) activity was elevated in the a-nTiO2 and POT groups. In lung tissue, oxidative stress index and proliferating cell nuclear antigen (PCNA) index were elevated in the a-nTiO2 and POT groups, and there was a significant elevation in C-C motif chemokine ligand 2 (CCL2) mRNA and protein in the POT group. In pleural cavity lavage, total protein was elevated in all 3 treatment groups, and LDH activity was elevated in the a-nTiO2 and POT groups. Importantly, the PCNA index of the visceral mesothelium was increased in the POT group. Overall, POT fibers had greater biopersistence, induced higher expression of CCL2, and provoked a stronger tissue response than a-nTiO2 or r-nTiO2.

Details

Title
Potassium octatitanate fibers induce persistent lung and pleural injury and are possibly carcinogenic in male Fischer 344 rats
Author
Abdelgied, Mohamed 1 ; El-Gazzar, Ahmed M 2 ; Alexander, David B 3   VIAFID ORCID Logo  ; Alexander, William T 3 ; Numano, Takamasa 3 ; Iigou, Masaaki 3 ; Naiki-Ito, Aya 4 ; Takase, Hirotsugu 5 ; Khaled Abbas Abdou 6 ; Hirose, Akihiko 7 ; Taquahashi, Yuhji 8 ; Kanno, Jun 9 ; Tsuda, Hiroyuki 3 ; Takahashi, Satoru 4 

 Nanotoxicology Project, Nagoya City University, Nagoya, Japan; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Beni Suef University, Beni-Suef, Egypt 
 Nanotoxicology Project, Nagoya City University, Nagoya, Japan; Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt 
 Nanotoxicology Project, Nagoya City University, Nagoya, Japan 
 Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan 
 Core Laboratory, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan 
 Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Beni Suef University, Beni-Suef, Egypt 
 Division of Risk Assessment, National Institute of Health Sciences, Tokyo, Japan 
 Division of Cellular and Molecular Toxicology, National Institute of Health Sciences, Tokyo, Japan 
 Japan Industrial Safety and Health Association, Japan Bioassay Research Center, Kanagawa, Japan 
Pages
2164-2177
Section
ORIGINAL ARTICLES
Publication year
2018
Publication date
Jul 2018
Publisher
John Wiley & Sons, Inc.
ISSN
13479032
e-ISSN
13497006
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2248512538
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.